199 related articles for article (PubMed ID: 19491211)
1. Nanoparticle-mediated expression of an angiogenic inhibitor ameliorates ischemia-induced retinal neovascularization and diabetes-induced retinal vascular leakage.
Park K; Chen Y; Hu Y; Mayo AS; Kompella UB; Longeras R; Ma JX
Diabetes; 2009 Aug; 58(8):1902-13. PubMed ID: 19491211
[TBL] [Abstract][Full Text] [Related]
2. Anti-inflammatory and antiangiogenic effects of nanoparticle-mediated delivery of a natural angiogenic inhibitor.
Jin J; Zhou KK; Park K; Hu Y; Xu X; Zheng Z; Tyagi P; Kompella UB; Ma JX
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6230-7. PubMed ID: 21357401
[TBL] [Abstract][Full Text] [Related]
3. Plasminogen kringle 5 reduces vascular leakage in the retina in rat models of oxygen-induced retinopathy and diabetes.
Zhang SX; Sima J; Shao C; Fant J; Chen Y; Rohrer B; Gao G; Ma JX
Diabetologia; 2004 Jan; 47(1):124-31. PubMed ID: 14666366
[TBL] [Abstract][Full Text] [Related]
4. Fenofibrate-Loaded Biodegradable Nanoparticles for the Treatment of Experimental Diabetic Retinopathy and Neovascular Age-Related Macular Degeneration.
Qiu F; Meng T; Chen Q; Zhou K; Shao Y; Matlock G; Ma X; Wu W; Du Y; Wang X; Deng G; Ma JX; Xu Q
Mol Pharm; 2019 May; 16(5):1958-1970. PubMed ID: 30912953
[TBL] [Abstract][Full Text] [Related]
5. Decreased K5 receptor expression in the retina, a potential pathogenic mechanism for diabetic retinopathy.
Ma J; Li C; Shao C; Gao G; Yang X
Mol Vis; 2012; 18():330-6. PubMed ID: 22355244
[TBL] [Abstract][Full Text] [Related]
6. Enhanced anti-angiogenic effect of a deletion mutant of plasminogen kringle 5 on neovascularization.
Cai W; Ma J; Li C; Yang Z; Yang X; Liu W; Liu Z; Li M; Gao G
J Cell Biochem; 2005 Dec; 96(6):1254-61. PubMed ID: 16167344
[TBL] [Abstract][Full Text] [Related]
7. Nanoparticle-mediated expression of a Wnt pathway inhibitor ameliorates ocular neovascularization.
Wang Z; Cheng R; Lee K; Tyagi P; Ding L; Kompella UB; Chen J; Xu X; Ma JX
Arterioscler Thromb Vasc Biol; 2015 Apr; 35(4):855-64. PubMed ID: 25657312
[TBL] [Abstract][Full Text] [Related]
8. Intravitreal injection of plasminogen kringle 5, an endogenous angiogenic inhibitor, arrests retinal neovascularization in rats.
Zhang D; Kaufman PL; Gao G; Saunders RA; Ma JX
Diabetologia; 2001 Jun; 44(6):757-65. PubMed ID: 11440369
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Effects of a Novel Agonist of Peroxisome Proliferator-Activated Receptor Alpha for the Treatment of Diabetic Retinopathy.
Deng G; Moran EP; Cheng R; Matlock G; Zhou K; Moran D; Chen D; Yu Q; Ma JX
Invest Ophthalmol Vis Sci; 2017 Oct; 58(12):5030-5042. PubMed ID: 28979999
[TBL] [Abstract][Full Text] [Related]
10. Acidic/neutral amino acid residues substitution in NH2 terminal of plasminogen kringle 5 exerts enhanced effects on corneal neovascularization.
Li C; Li L; Cheng R; Dai Z; Li C; Yao Y; Zhou T; Yang Z; Gao G; Yang X
Cornea; 2013 May; 32(5):680-8. PubMed ID: 23343948
[TBL] [Abstract][Full Text] [Related]
11. Systemic and periocular deliveries of plasminogen kringle 5 reduce vascular leakage in rat models of oxygen-induced retinopathy and diabetes.
Zhang SX; Sima J; Wang JJ; Shao C; Fant J; Ma JX
Curr Eye Res; 2005 Aug; 30(8):681-9. PubMed ID: 16109649
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic potential of a monoclonal antibody blocking the Wnt pathway in diabetic retinopathy.
Lee K; Hu Y; Ding L; Chen Y; Takahashi Y; Mott R; Ma JX
Diabetes; 2012 Nov; 61(11):2948-57. PubMed ID: 22891217
[TBL] [Abstract][Full Text] [Related]
13. Plasminogen kringle 5 inhibits alkali-burn-induced corneal neovascularization.
Zhang Z; Ma JX; Gao G; Li C; Luo L; Zhang M; Yang W; Jiang A; Kuang W; Xu L; Chen J; Liu Z
Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):4062-71. PubMed ID: 16249481
[TBL] [Abstract][Full Text] [Related]
14. Sustained therapeutic effect of an anti-inflammatory peptide encapsulated in nanoparticles on ocular vascular leakage in diabetic retinopathy.
Qu Q; Park K; Zhou K; Wassel D; Farjo R; Criswell T; Ma JX; Zhang Y
Front Cell Dev Biol; 2022; 10():1049678. PubMed ID: 36589744
[TBL] [Abstract][Full Text] [Related]
15. Single periocular injection of celecoxib-PLGA microparticles inhibits diabetes-induced elevations in retinal PGE2, VEGF, and vascular leakage.
Amrite AC; Ayalasomayajula SP; Cheruvu NP; Kompella UB
Invest Ophthalmol Vis Sci; 2006 Mar; 47(3):1149-60. PubMed ID: 16505053
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of vascular endothelial growth factor and up-regulation of pigment epithelium-derived factor: a possible mechanism for the anti-angiogenic activity of plasminogen kringle 5.
Gao G; Li Y; Gee S; Dudley A; Fant J; Crosson C; Ma JX
J Biol Chem; 2002 Mar; 277(11):9492-7. PubMed ID: 11782462
[TBL] [Abstract][Full Text] [Related]
17. Kallikrein-binding protein inhibits retinal neovascularization and decreases vascular leakage.
Gao G; Shao C; Zhang SX; Dudley A; Fant J; Ma JX
Diabetologia; 2003 May; 46(5):689-98. PubMed ID: 12743698
[TBL] [Abstract][Full Text] [Related]
18. Aquaporin 4 knockdown exacerbates streptozotocin-induced diabetic retinopathy through aggravating inflammatory response.
Cui B; Sun JH; Xiang FF; Liu L; Li WJ
Exp Eye Res; 2012 May; 98():37-43. PubMed ID: 22449442
[TBL] [Abstract][Full Text] [Related]
19. Therapeutic potential of elema-1,3,7(11),8-tetraen-8,12-lactam from Curcuma wenyujin on diabetic retinopathy via anti-inflammatory and anti-angiogenic pathways.
Cai Y; Tu H; Wu C; Liu T; Chen S; Shen L; Xiao Q; Zhao S; Xu S; Lin W; Yan P; Dong J
J Ethnopharmacol; 2024 Jan; 318(Pt A):116843. PubMed ID: 37414197
[TBL] [Abstract][Full Text] [Related]
20. Combined effects of PLGA and vascular endothelial growth factor promote the healing of non-diabetic and diabetic wounds.
Chereddy KK; Lopes A; Koussoroplis S; Payen V; Moia C; Zhu H; Sonveaux P; Carmeliet P; des Rieux A; Vandermeulen G; Préat V
Nanomedicine; 2015 Nov; 11(8):1975-84. PubMed ID: 26238081
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
